Research ArticleArticle
Open Access
Long-Term Opioid Therapy Among Patients With Systemic Lupus Erythematosus in the Community: A Lupus Midwest Network (LUMEN) Study
Gabriel Figueroa-Parra, Molly M. Jeffery, Jesse Y. Dabit, Baptiste Chevet, Maria O. Valenzuela-Almada, Mehmet Hocaoglu, Shirley-Ann Osei-Onomah, Shaheen Kurani, Sebastian Vallejo, Sara J. Achenbach, W. Michael Hooten, Kamil E. Barbour, Cynthia S. Crowson and Alí Duarte-García
The Journal of Rheumatology November 2022, jrheum.220822; DOI: https://doi.org/10.3899/jrheum.220822
Gabriel Figueroa-Parra
The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) under grant number U01 DP006491 as part of a financial assistance award totaling US $1,750,000 with 100% funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the US Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health (NIH) under award number R01AG034676 and grant number UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the NIH. The content is solely the authors' responsibility and does not necessarily represent the official views of the NIH. ADG is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past 3 years, MMJ has received unrelated grant funding from the Agency for Healthcare Research and Quality; the National Institute on Drug Abuse; the National Heart, Lung, and Blood Institute; the American Cancer Society; and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program. G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, and Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Duarte-García, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Email: duarte.ali@mayo.edu. Accepted for publication October 24, 2022.
Molly M. Jeffery
The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) under grant number U01 DP006491 as part of a financial assistance award totaling US $1,750,000 with 100% funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the US Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health (NIH) under award number R01AG034676 and grant number UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the NIH. The content is solely the authors' responsibility and does not necessarily represent the official views of the NIH. ADG is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past 3 years, MMJ has received unrelated grant funding from the Agency for Healthcare Research and Quality; the National Institute on Drug Abuse; the National Heart, Lung, and Blood Institute; the American Cancer Society; and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program. G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, and Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Duarte-García, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Email: duarte.ali@mayo.edu. Accepted for publication October 24, 2022.
Jesse Y. Dabit
The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) under grant number U01 DP006491 as part of a financial assistance award totaling US $1,750,000 with 100% funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the US Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health (NIH) under award number R01AG034676 and grant number UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the NIH. The content is solely the authors' responsibility and does not necessarily represent the official views of the NIH. ADG is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past 3 years, MMJ has received unrelated grant funding from the Agency for Healthcare Research and Quality; the National Institute on Drug Abuse; the National Heart, Lung, and Blood Institute; the American Cancer Society; and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program. G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, and Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Duarte-García, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Email: duarte.ali@mayo.edu. Accepted for publication October 24, 2022.
Baptiste Chevet
The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) under grant number U01 DP006491 as part of a financial assistance award totaling US $1,750,000 with 100% funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the US Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health (NIH) under award number R01AG034676 and grant number UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the NIH. The content is solely the authors' responsibility and does not necessarily represent the official views of the NIH. ADG is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past 3 years, MMJ has received unrelated grant funding from the Agency for Healthcare Research and Quality; the National Institute on Drug Abuse; the National Heart, Lung, and Blood Institute; the American Cancer Society; and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program. G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, and Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Duarte-García, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Email: duarte.ali@mayo.edu. Accepted for publication October 24, 2022.
Maria O. Valenzuela-Almada
The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) under grant number U01 DP006491 as part of a financial assistance award totaling US $1,750,000 with 100% funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the US Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health (NIH) under award number R01AG034676 and grant number UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the NIH. The content is solely the authors' responsibility and does not necessarily represent the official views of the NIH. ADG is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past 3 years, MMJ has received unrelated grant funding from the Agency for Healthcare Research and Quality; the National Institute on Drug Abuse; the National Heart, Lung, and Blood Institute; the American Cancer Society; and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program. G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, and Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Duarte-García, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Email: duarte.ali@mayo.edu. Accepted for publication October 24, 2022.
Mehmet Hocaoglu
The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) under grant number U01 DP006491 as part of a financial assistance award totaling US $1,750,000 with 100% funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the US Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health (NIH) under award number R01AG034676 and grant number UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the NIH. The content is solely the authors' responsibility and does not necessarily represent the official views of the NIH. ADG is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past 3 years, MMJ has received unrelated grant funding from the Agency for Healthcare Research and Quality; the National Institute on Drug Abuse; the National Heart, Lung, and Blood Institute; the American Cancer Society; and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program. G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, and Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Duarte-García, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Email: duarte.ali@mayo.edu. Accepted for publication October 24, 2022.
Shirley-Ann Osei-Onomah
The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) under grant number U01 DP006491 as part of a financial assistance award totaling US $1,750,000 with 100% funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the US Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health (NIH) under award number R01AG034676 and grant number UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the NIH. The content is solely the authors' responsibility and does not necessarily represent the official views of the NIH. ADG is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past 3 years, MMJ has received unrelated grant funding from the Agency for Healthcare Research and Quality; the National Institute on Drug Abuse; the National Heart, Lung, and Blood Institute; the American Cancer Society; and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program. G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, and Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Duarte-García, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Email: duarte.ali@mayo.edu. Accepted for publication October 24, 2022.
Shaheen Kurani
The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) under grant number U01 DP006491 as part of a financial assistance award totaling US $1,750,000 with 100% funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the US Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health (NIH) under award number R01AG034676 and grant number UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the NIH. The content is solely the authors' responsibility and does not necessarily represent the official views of the NIH. ADG is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past 3 years, MMJ has received unrelated grant funding from the Agency for Healthcare Research and Quality; the National Institute on Drug Abuse; the National Heart, Lung, and Blood Institute; the American Cancer Society; and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program. G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, and Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Duarte-García, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Email: duarte.ali@mayo.edu. Accepted for publication October 24, 2022.
Sebastian Vallejo
The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) under grant number U01 DP006491 as part of a financial assistance award totaling US $1,750,000 with 100% funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the US Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health (NIH) under award number R01AG034676 and grant number UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the NIH. The content is solely the authors' responsibility and does not necessarily represent the official views of the NIH. ADG is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past 3 years, MMJ has received unrelated grant funding from the Agency for Healthcare Research and Quality; the National Institute on Drug Abuse; the National Heart, Lung, and Blood Institute; the American Cancer Society; and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program. G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, and Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Duarte-García, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Email: duarte.ali@mayo.edu. Accepted for publication October 24, 2022.
Sara J. Achenbach
The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) under grant number U01 DP006491 as part of a financial assistance award totaling US $1,750,000 with 100% funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the US Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health (NIH) under award number R01AG034676 and grant number UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the NIH. The content is solely the authors' responsibility and does not necessarily represent the official views of the NIH. ADG is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past 3 years, MMJ has received unrelated grant funding from the Agency for Healthcare Research and Quality; the National Institute on Drug Abuse; the National Heart, Lung, and Blood Institute; the American Cancer Society; and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program. G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, and Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Duarte-García, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Email: duarte.ali@mayo.edu. Accepted for publication October 24, 2022.
W. Michael Hooten
The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) under grant number U01 DP006491 as part of a financial assistance award totaling US $1,750,000 with 100% funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the US Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health (NIH) under award number R01AG034676 and grant number UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the NIH. The content is solely the authors' responsibility and does not necessarily represent the official views of the NIH. ADG is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past 3 years, MMJ has received unrelated grant funding from the Agency for Healthcare Research and Quality; the National Institute on Drug Abuse; the National Heart, Lung, and Blood Institute; the American Cancer Society; and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program. G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, and Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Duarte-García, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Email: duarte.ali@mayo.edu. Accepted for publication October 24, 2022.
Kamil E. Barbour
The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) under grant number U01 DP006491 as part of a financial assistance award totaling US $1,750,000 with 100% funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the US Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health (NIH) under award number R01AG034676 and grant number UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the NIH. The content is solely the authors' responsibility and does not necessarily represent the official views of the NIH. ADG is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past 3 years, MMJ has received unrelated grant funding from the Agency for Healthcare Research and Quality; the National Institute on Drug Abuse; the National Heart, Lung, and Blood Institute; the American Cancer Society; and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program. G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, and Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Duarte-García, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Email: duarte.ali@mayo.edu. Accepted for publication October 24, 2022.
Cynthia S. Crowson
The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) under grant number U01 DP006491 as part of a financial assistance award totaling US $1,750,000 with 100% funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the US Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health (NIH) under award number R01AG034676 and grant number UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the NIH. The content is solely the authors' responsibility and does not necessarily represent the official views of the NIH. ADG is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past 3 years, MMJ has received unrelated grant funding from the Agency for Healthcare Research and Quality; the National Institute on Drug Abuse; the National Heart, Lung, and Blood Institute; the American Cancer Society; and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program. G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, and Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Duarte-García, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Email: duarte.ali@mayo.edu. Accepted for publication October 24, 2022.
Alí Duarte-García
The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention (CDC) of the US Department of Health and Human Services (HHS) under grant number U01 DP006491 as part of a financial assistance award totaling US $1,750,000 with 100% funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the US Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health (NIH) under award number R01AG034676 and grant number UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the NIH. The content is solely the authors' responsibility and does not necessarily represent the official views of the NIH. ADG is supported by the Rheumatology Research Foundation Scientist Development Award and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the past 3 years, MMJ has received unrelated grant funding from the Agency for Healthcare Research and Quality; the National Institute on Drug Abuse; the National Heart, Lung, and Blood Institute; the American Cancer Society; and the US Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program. G. Figueroa-Parra, MD, J.Y. Dabit, MD, MS, M.O. Valenzuela-Almada, MD, M. Hocaoglu, MD, S.A. Osei-Onomah, MPH, S. Vallejo, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. M.M. Jeffery, PhD, Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, and Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. S. Kurani, PhD, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. S.J. Achenbach, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. W.M. Hooten, MD, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, and Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. A. Duarte-García, MD, MSc, Division of Rheumatology, Mayo Clinic, and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. A. Duarte-García, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Email: duarte.ali@mayo.edu. Accepted for publication October 24, 2022.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Long-Term Opioid Therapy Among Patients With Systemic Lupus Erythematosus in the Community: A Lupus Midwest Network (LUMEN) Study
Gabriel Figueroa-Parra, Molly M. Jeffery, Jesse Y. Dabit, Baptiste Chevet, Maria O. Valenzuela-Almada, Mehmet Hocaoglu, Shirley-Ann Osei-Onomah, Shaheen Kurani, Sebastian Vallejo, Sara J. Achenbach, W. Michael Hooten, Kamil E. Barbour, Cynthia S. Crowson, Alí Duarte-García
The Journal of Rheumatology Nov 2022, jrheum.220822; DOI: 10.3899/jrheum.220822
Long-Term Opioid Therapy Among Patients With Systemic Lupus Erythematosus in the Community: A Lupus Midwest Network (LUMEN) Study
Gabriel Figueroa-Parra, Molly M. Jeffery, Jesse Y. Dabit, Baptiste Chevet, Maria O. Valenzuela-Almada, Mehmet Hocaoglu, Shirley-Ann Osei-Onomah, Shaheen Kurani, Sebastian Vallejo, Sara J. Achenbach, W. Michael Hooten, Kamil E. Barbour, Cynthia S. Crowson, Alí Duarte-García
The Journal of Rheumatology Nov 2022, jrheum.220822; DOI: 10.3899/jrheum.220822